Marie Curie Cancer Care Research Programme
The aim of the Marie Curie Cancer Care (MCCC) Research Programme is to provide evidence to inform better quality of care for those with advanced and progressive illnesses which are likely to shorten their lives within the foreseeable future.
Marie Curie Cancer Care is spending up to £1 million per year to fund high quality research with the potential to improve palliative and end of life care for those with cancer and/or other advanced progressive life threatening conditions.
Marie Curie Cancer Care will be assisted by Cancer Research UK, who will administer the application process and grant funding.
What is covered
Applications are considered in the following areas:
- Interfaces between specialist palliative care and other forms of care at the end of life
- Prognostication
- End of life care and younger adults
All types of methodologies are welcome, and methodological rigour and feasibility of the research plans will be paramount. In their proposals, applicants should cite existing relevant evidence, including any systematic reviews, and make reference to relevant UK End of Life Care strategic documents. Research should address issues relevant to the last year of life.
Applications are judged on the basis of scientific excellence, methodological rigour, fit with the remit and potential impact of the proposal.
Eligibility
Applications will be accepted from scientists, clinicians or health care workers in UK universities, medical schools, hospitals and some research institutions.
Period of funding
Funding is provided for up to 36 months.
Funding value
No set value.
How to apply
All Marie Curie Cancer Care Research Programme Project Grant applications must be made online.
Increase text
Decrease text
Print this page